Protech Home Medical adds Gene Ewing to its Board of Directors

– USA, KY – Protech Home Medical Corp. (TSXV:PHM), a healthcare services company with operations in the U.S, today announced the appointment of D. Eugene Ewing to the Company’s board of directors. The addition of Mr. Ewing represents the next phase of Protech’s corporate evolution and strengthening of the Company’s non-executive board of directors in anticipation of executing on its previously announced revised corporate strategy.

Mr. D. Eugene Ewing has over 30 years of professional experience in a wide range of executive positions and brings a wealth of corporate knowledge across a variety of industry groups. He currently serves as an independent director of Darling Ingredients Inc., a New York Stock Exchange listed company focused on creating sustainable food, feed and fuel solutions from organic by-products, where he serves as Chairman of the Audit Committee and as a member of the Nominating and Governance Committee. He also serves as an independent director of Compass Diversified Holdings, a New York Stock Exchange listed company that owns and manages controlling interests in a diverse family of established North American middle market businesses, where he also serves as Chairman of the Audit Committee and as a member of the Compensation and Nominating/Corporate Governance Committees.

In addition to his public company roles, Mr. Ewing has been the managing member of Deeper Water Consulting, a private wealth and business consulting company, since March of 2004. Previously, Mr. Ewing held senior positions at the Fifth Third Bank, ranked 17th in 2018 in total assets for U.S. banks, and was a tax partner at Arthur Andersen LLP for over 15 years, in Cincinnati, Ohio. Mr. Ewing is also on the Advisory Board for the Von Allmen School of Accountancy at the University of Kentucky and is also a director of a private trust company located in Wyoming and a private consulting company located in California.

As a former partner with what was once one of the U.S.’s largest certified public accounting firms, and with more than 30 years of business planning and transaction experience in a wide variety of industries and circumstances, Mr. Ewing brings to the Protech board significant experience in complex accounting, reporting and taxation matters and SEC filings and corporate merger and acquisition transactions. Mr. Ewing’s financial certifications and education, along with his current and past experiences, makes him uniquely qualified to Chair the Audit Committee of Protech.

“I am thrilled to have someone with Gene’s experience joining our board at this time,” said Greg Crawford, Chief Executive Officer and Chairman of the Board of Protech. “We look forward to Gene’s guidance and his assisting us in reaching our goal to build a world-class healthcare company. Our management team is exceptionally excited about pursuing our patient-focused, technology-enabled strategy. And we are ever confident that this strategy will result in improved financial performance and increased shareholder value over time. An experienced, independent Board coupled with a highly talented executive team are key ingredients to our future success.”

About Protech Home Medical

Protech provides equipment, services and supplies for disease management for patients in the United States healthcare market. It seeks to expand its product and services offerings and to employ technology to attain dominant market share in select U.S. regional markets. It undertakes this strategy by means of business acquisitions and by taking market share directly from competitors.

For more information : http://www.protechhomemedical.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team

here the original post =>